Impact of High Immunoreactivity on Surgically Treated Serum p53 Antibody-Positive Esophageal Squamous Cell Carcinoma after Neoadjuvant Therapy: A Multi-Institutional Study of 637 Cases
Annals of Thoracic and Cardiovascular Surgery · 2026
DOI: 10.5761/atcs.oa.26-00142 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Annals of Thoracic and Cardiovascular Surgery, 2026. Verfasst von Takashi Suzuki und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterological Surgery and Clinical Oncology, Graduate School of Medicine, Toho University, Tokyo, Japan. Hauptthemen laut MEDLINE: Neoadjuvant Therapy, Tumor Suppressor Protein p53, Esophageal Neoplasms, Biomarkers, Tumor. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
PURPOSE: This multi-institutional study investigated the clinical and prognostic significance of serum p53 antibody (s-p53-Ab) titers in patients with s-p53-Ab-positive esophageal squamous cell carcinoma (ESCC) treated with neoadjuvant chemotherapy (NAC). METHODS: We analyzed 637 patients who underwent surgery at 15 institutions. Patients were divided into upfront surgery (n = 375) and NAC (n = 262) groups and stratified into high-titer (≥9.82 ng/mL) and low-titer (>1.30 to
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterological Surgery and Clinical Oncology, Graduate School of Medicine, Toho University, Tokyo, Japan.
- Department of Gastroenterological Surgery, Gastroenterology Center, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
- Department of Digestive Surgery, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan.
- Department of Gastroenterological Surgery, Toranomon Hospital, and Okinaka Memorial Institute for Medical Research, Tokyo, Japan.
- Department of Gastrointestinal Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
- Department of Gastroenterological Surgery, Saitama Cancer Center Hospital, Kitaadachi-gun, Saitama, Japan.
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Suzuki, T., Yajima, S., Okamura, A., Taniyama, Y., Ohkura, Y., Yagi, K., Fukuda, T., Ogawa, R., Tsubosa, Y., & Shimada, H. (2026). Impact of High Immunoreactivity on Surgically Treated Serum p53 Antibody-Positive Esophageal Squamous Cell Carcinoma after Neoadjuvant Therapy: A Multi-Institutional Study of 637 Cases. Annals of Thoracic and Cardiovascular Surgery. https://doi.org/10.5761/atcs.oa.26-00142
Vancouver
Suzuki T, Yajima S, Okamura A, Taniyama Y, Ohkura Y, Yagi K, et al. Impact of High Immunoreactivity on Surgically Treated Serum p53 Antibody-Positive Esophageal Squamous Cell Carcinoma after Neoadjuvant Therapy: A Multi-Institutional Study of 637 Cases. Annals of Thoracic and Cardiovascular Surgery. 2026. doi:10.5761/atcs.oa.26-00142
BibTeX
@article{Suzuki2026,
author = {Suzuki, Takashi and Yajima, Satoshi and Okamura, Akihiko and Taniyama, Yusuke and Ohkura, Yu and Yagi, Koichi and Fukuda, Takashi and Ogawa, Ryo and Tsubosa, Yasuhiro and Shimada, Hideaki},
title = {Impact of High Immunoreactivity on Surgically Treated Serum p53 Antibody-Positive Esophageal Squamous Cell Carcinoma after Neoadjuvant Therapy: A Multi-Institutional Study of 637 Cases},
journal = {Annals of Thoracic and Cardiovascular Surgery},
year = {2026},
doi = {10.5761/atcs.oa.26-00142}
}
EUVIMED